Undiagnosed hypertension and proteinuria in an outpatient population in Northern Ghana
DOI:
https://doi.org/10.18203/2320-6012.ijrms20240200Keywords:
Hypertension, Proteinuria, Chronic kidney disease, GhanaAbstract
Background: There is an upsurge in chronic kidney disease incidence worldwide. Late presentation characterises chronic kidney disease in sub-Saharan Africa. Hypertension and proteinuria are independent risk factors for worsening kidney function, irrespective of the cause of the kidney disease. We assessed the prevalence and predictors of hypertension and proteinuria in an outpatient population in Northern Ghana.
Methods: We retrospectively reviewed screening data among adults ≥18 years of age in two of Ghana’s Northern regions. The data retrieved included socio-demographic information, blood pressure recordings, urine dipsticks and fingerpick blood glucose levels. The data were analysed for the prevalence of hypertension and proteinuria in the participants. Binary logistic regression analysis was employed to identify the predictors of significant proteinuria in these participants. A p-value <0.05 was considered statistically significant.
Results: Total 1018 participants were included in the study, comprising 50.5% males. The prevalence of uncontrolled hypertension was 28.1%, using a blood pressure cut-off value of ≥ 140/90 mmHg. Significant proteinuria (≥ 1+ or 30 mg/dl) was present in 10.7% of the participants. Hypertension (AOR 2.433, 95% CI 1.582-3.742, p<0.001) and hyperglycaemia (AOR 2.226, 95% CI 1.159-4.275, p=0.016) were independent predictors of the presence of significant proteinuria.
Conclusions: Uncontrolled hypertension and proteinuria were common in this outpatient population in Northern Ghana. The cost-effectiveness of community-based screening for chronic kidney disease and its risk factors in low-resource settings like Ghana, with the aim to treat to improve outcomes, needs to be explored.
References
Arogundade FA, Barsoum RS. CKD Prevention in Sub-Saharan Africa: A Call for Governmental, Nongovernmental, and Community Support. Am J Kidney Dis. 2008;51(3):515-23.
Osafo C, Mate-Kole M, Affram K, Adu D. Prevalence of chronic kidney disease in hypertensive patients in Ghana. Ren Fail. 2011;33(4):388-92.
Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, et al. Blood pressure control, proteinuria, and the progression of renal disease: The modification of diet in renal disease study. Ann Intern Med. 1995;123(10):754-62.
Cravedi P, Ruggenenti P, Remuzzi G. Proteinuria should be used as a surrogate in CKD. Nat Rev Nephrol. 2012;8(5):301-6.
Ulasi II, Ijoma CK, Onodugo OD, Ulasi, II, Ijoma CK OO. A community-based study of hypertension and cardio-metabolic syndrome in semi-urban and rural communities in Nigeria. BMC Heal Serv Res. 2010;10(1):71.
Oladapo OO, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase a O. A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey. Cardiovasc J Afr. 2010;21(1):26-31.
Pobee JOM, Larbi EB, Belcher DW, Wurapa FK, Dodu SRA. Blood pressure distribution in a rural ghanaian population. Trans R Soc Trop Med Hyg. 1977;71(1):66-72.
Bosu WK. Epidemic of hypertension in Ghana: a systematic review. BMC Publ Heal. 2010;10(1):1-4.
Oluyombo R, Ayodele OE, Akinwusi PO, Okunola OO, Gbadegesin BA, Soje M, et al. Awareness, knowledge and perception of chronic kidney disease in a rural community of South-West Nigeria. Niger J Clin Pract. 2016;19(2):161-9.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260-72.
Ghana Statistical Service. 2010 Population and Housing Census: Regional Analytical Report. 2013;9(8):3.
International Society of Nephrology. Kidney Health for All: Welcome to the World Kidney Day 2022 Campaign, 2022. Available at: https://www.theisn.org/blog/2021/09/20/kidney-health-for-all-welcome-to-the-world-kidney-day-2022-campaign/. Accessed 6 Jan 2024.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypert. 2020;75(6):1334-57.
Siemens. Multistix 10 SG Reagent Strips, 2014. Available at: https://www.siemens-healthineers.com/urinalysis-products/urinalysis-reagents/multistix-10-sg-reagent-strips. Accessed 6 Jan 2024.
Sumida K, Nadkarni GN, Grams ME, Sang Y, Ballew SH, Coresh J, et al. Conversion of urine protein–creatinine ratio or urine dipstick protein to urine albumin–creatinine ratio for use in chronic kidney disease screening and prognosis: An individual participant–based meta-analysis. Ann Intern Med. 2020;173(6):426-35.
Evans PD, Taal MW. Epidemiology and causes of chronic kidney disease. Med (United Kingdom). 2015;43(8):450-3.
Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in sub-saharan africa: A systematic review and meta-analysis. Hyper. 2015;65(2):291-8.
Bosu WK, Bosu DK. Prevalence, awareness and control of hypertension in Ghana: A systematic review and meta-analysis. PLoS One. 2021;16(3):e0248137.
Cohen JB, Schrauben SJ, Zhao L, Basso MD, Cvijic ME, Li Z, et al. Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone. JACC Hear Fail. 2020;8(3):172-84.
Okwuonu C, Ojimadu N, Chimezie O, Madudonu U, Ogbulafor N, Ogah O. Awareness of blood pressure status, undiagnosed hypertension and proteinuria among adults in Umuahia, South-East Nigeria. Sahel Med J. 2016;19(2):82.
Kaze AD, Ilori T, Jaar BG, Echouffo-Tcheugui JB. Burden of chronic kidney disease on the African continent: A systematic review and meta-analysis. BMC Nephrol. 2018;19(1).
Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Am J Cardiol. 1997;80(2):164-9.
Klausen KP, Scharling H, Jensen JS. Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. J Intern Med. 2006;260(3):231-7.
Cravedi P, Remuzzi G. Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br J Clin Pharmacol. 2013;76(4):516-23.
Berns JS. Routine screening for CKD should be done in asymptomatic adults … selectively. Clin J Am Soc Nephrol. 2014;9(11):1988-92.
Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2021;99(1):34-47.
Ameh OI, Ekrikpo UE, Kengne AP. Preventing CKD in low- and middle-income countries: a call for urgent action. Kidney Int Reports. 2020;5(3):255-62.
Flood D, Garcia P, Douglas K, Hawkins J, Rohloff P. Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala: A cross-sectional study. BMJ Open. 2018;8(1):e019778.
Lim D, Lee DY, Cho SH, Kim OZ, Cho SW, An SK, et al. Diagnostic accuracy of urine dipstick for proteinuria in older outpatients. Kidney Res Clin Pract. 2014;33(4):199-203.
White S, Agarwal R. Urine dipstick readings ≥1+ had limited sensitivity but high specificity for detecting albuminuria in adults. Ann Intern Med. 2011;155(8).
Bradshaw C, Kondal D, Montez-Rath ME, Han J, Zheng Y, Shivashankar R, et al. Early detection of chronic kidney disease in low-income and middle-income countries: Development and validation of a point-of-care screening strategy for India. BMJ Glob Heal. 2019;4(5):e001644.
